Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review von Iheanacho, Ike, Zhang, Shiyuan, King, Denise, Rizzo, Maria, Ismaila, Afisi S.

Volltext

P51 EFFICACY AND SAFETY OF THIRD‐LINE OR LATER TREATMENTS, INCLUDING THE CD38 MONOCLONAL ANTIBODY CLASS, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC LITERAT... von Hanna, M., Chorazy, J., Iheanacho, I., Gorsh, B., Wang, P.F., Paka, P., Perera, S.

Volltext

A Systematic Literature Review of the Economic Burden in Multiple Myeloma von Rizzo, M, Xu, Y, Panjabi, S, Iheanacho, I

Volltext

A Systematic Literature Review of the Humanistic Burden of Multiple Myeloma von Rizzo, M, Xu, Y, Panjabi, S, Iheanacho, I

Volltext

Faulty Connections: Can Criticisms of Network Meta-Analysis in Nice Submissions Be Avoided? von Martin, A, Rizzo, M, Iheanacho, I

Volltext

Mortality and Survival in Inoperable or Residual/Recurrent Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Systematic Literature Review von Byrnes, M.J, Ashaye, A.O, Iheanacho, I, Travers, K, Sikirica, M

Volltext

A Systematic Literature Review on the Epidemiology and Economic Burden of Anaemia Associated with Chronic Kidney Disease von Rizzo, M, Iheanacho, I, van Nooten, F.E, Goldsmith, D

Volltext

PRO67 Does Society Support The Prioritisation Of High-Cost Treatments For Rare Diseases? A Systematic Literature Review von Dodman, S., Iheanacho, I., Koufopoulou, M.

Volltext

PRO9 What's Clear About Assessing Airway Clearance Techniques in Cystic Fibrosis?: A Systematic Literature Review von Milenković, D., GomezEspinosa, E., Iheanacho, I.

Volltext

SA59 Is There Life for Pre-Prints After COVID-19? von Wittkopf, P, Raorane, R, Casañas i Comabella, C, Iheanacho, I

Volltext

HTA137 Evidence Review Group Criticism of Clinical Effectiveness Systematic Reviews in NICE Oncology Submissions von Borkowska, K, Pustulka, I, Chorazy, J, Ajith, A, Iheanacho, I

Volltext

CO75 Clinical Outcomes Associated with Anti-CD38 Retreatment in Relapsed/Refractory Multiple Myeloma: A Review of the Literature von McNamara, S., Chorazy, J., Pandey, A., Bitetti, J., Boytsov, N., Purser, M., Iheanacho, I.

Volltext

Rosiglitazone in the UK: down but not out von Iheanacho, Ike

Volltext

PRO89 TOO ULTRA-RARE FOR CARE? ORPHAN DRUG AVAILABILITY FOR RESPIRATORY DISEASES: A SYSTEMATIC REVIEW von Matthews, H., Lovelace, M., Freitag, A., Iheanacho, I.

Volltext

PMU123 DO SYSTEMATIC REVIEWS SYSTEMATICALLY ASSESS RISK OF BIAS IN REAL-WORLD EVIDENCE STUDIES? von Kazmierska, P., GomezEspinosa, E., Deshpande, S., Iheanacho, I.

Volltext

Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systemati... von Czira, Alexandrosz, Purushotham, Sneha, Iheanacho, Ike, Rothnie, Kieran J, Compton, Chris, Ismaila, Afisi S

Volltext

Sorry, you’re barred von Iheanacho, Ike

Volltext

PRM235 - What's the Reality of Real-World Evidence in Health Technology Appraisal? von Sarri, G, Lambrelli, D, Gulea, C, GomezEspinosa, E, Iheanacho, I

Volltext

What's the Reality of Real-World Evidence in Health Technology Appraisal? von Sarri, G, Lambrelli, D, Gulea, C, GomezEspinosa, E, Iheanacho, I

Volltext

PNS202 PARALLEL SCIENTIFIC ADVICE FROM NICE AND CADTH: WHAT'S IN IT FOR MANUFACTURERS? von Vania, D.K., Boss, J., Molenkamp, L., Hurley, P.T., Iheanacho, I., Bending, M., Deshpande, S.

Volltext